This test is not yet available. Please subscribe to our email list for updates.

At-home test for novel coronavirus

In response to the COVID-19 outbreak (caused by novel coronavirus SARS-CoV-2), Lemonaid and Scanwell are working together to develop and distribute a test for at-home use.


April 8, 2020

Another weekly update from the Scanwell team.

In this video Dr. Jack Jeng (chief medical officer at Scanwell) and Pavel Bozdog (lead engineer at Scanwell) talk about the clinical trial protocol we have submitted to the FDA, as well as the individual components of the test.

April 1, 2020

Another weekly update from the Scanwell team.

In this video Dr. Jack Jeng (chief medical officer at Scanwell) and Pavel Bozdog (lead engineer at Scanwell) talk about some of the usability testing we've been conducting, and where we're at in the process of obtaining emergency use authorization (EUA) from the FDA.

March 25, 2020

As the Scanwell and Lemonaid teams work diligently to make our novel coronavirus at-home test available, we wanted to share regular updates on our progress.

In this video, Dr. Jack Jeng (chief medical officer at Scanwell) and Pavel Bozdog (lead engineer at Scanwell) share what the team has been working on in the past week, what's on deck, and how the March 20th statement from the FDA affects the project.

How the at-home test will work:

  1. Patient completes online intake questionnaire to be evaluated by a Lemonaid doctor or nurse practitioner.

  2. If appropriate, the Lemonaid doctor or nurse practitioner will order a test for the patient, following guidelines established by the CDC.

  3. After the test is ordered, it will be mailed out to the patient via next business day delivery.

  4. Once received, patient completes at-home test following instructions from the Scanwell smartphone app. Afterward, test results will be securely shared back to Lemonaid.

  5. Patient receives follow-up consultation with a Lemonaid doctor or nurse practitioner, who will advise on next steps (self-quarantine, confirmatory testing, in-person care, etc.)

Scanwell novel coronavirus COVID-19 test

About the project

The program will be provided at cost ($70, no insurance required). A breakdown of pricing is below:

Online consult

A Lemonaid doctor or nurse practitioner will order and interpret your test, then consult with you on next steps.

The cost of the online consultation is $25.


The tests are manufactured by biotechnology company INNOVITA. The testing process also requires the use of a blood collection device and other components.

The INNOVITA test and other testing components cost Scanwell $10.


All tests will be shipped next business day. Depending on where you are located, shipping can cost between $25 and $75.

We have established a flat fee of $25 for shipping and will absorb any additional costs.


Labor includes picking and packing all test kit components, and fulfillment of finished test kits.

The cost of labor is $10.

Lemonaid Health

Lemonaid Health is leading the next wave of telemedicine innovation and medicine delivery. We use clinical algorithms to augment our physician's knowledge as the basis for our platform that enables patients to quickly, safely and inexpensively get care and prescriptions for a variety of common medical conditions. Our mail order pharmacy typically mails medicine same day. Our medical team, website and mobile app have garnered an industry-leading Net Promoter Score of 89 and our telehealth practice has processed hundreds of thousands of visits nationally.

Scanwell Health

Scanwell Health makes healthcare more accessible through smartphone-enabled, at-home diagnostics. Scanwell’s innovative approach lets people test from anywhere, skip the waiting room and get same-day results. By quickly diagnosing acute illnesses, chronic diseases and rare conditions, Scanwell accelerates the path to treatment. The company’s first offering is the only FDA-cleared over-the-counter app that provides testing and treatment for urinary tract infections (UTIs).

Frequently asked questions

Below are answers to the most frequently asked questions about the Scanwell SARS-CoV-2 Rapid Test. If you do not see your question answered below, please email us at

This test is a rapid serology test. It detects IgM and IgG antibodies against novel coronavirus SARS-CoV-2 in the blood, which indicates that a person has been exposed and developed antibodies against the virus. 

This type of test will indicate whether or not you have been exposed and developed antibodies against the virus. Serological testing is helpful in identifying large numbers of infected patients and asymptomatic carriers, ultimately supporting containment efforts and slowing the spread of the virus.

It may not detect an infection early on if antibodies haven't been produced yet. When the results are positive and patients are asymptomatic, it is unclear if they are contagious and need to be quarantined.

Overall, the results may be less accurate than traditional PCR tests.

We hope to make these tests available within 6 to 8 weeks after obtaining Emergency Use Authorization (EUA) from the FDA for at-home use of serology tests. We will post updates on this site.

To obtain the test, you will first have to complete an online intake questionnaire. A doctor or nurse practitioner will evaluate your questionnaire, and if appropriate, will order the test for you. They will be following test ordering guidelines established by the CDC based on the most recent evidence and current capacity constraints.

If you would like be notified when
the test is available, please sign up for updates.

Thank you! We'll be in touch soon.
Please enter a valid email address or email us at